Streetbeat News

Revenues

SWKS

Skyworks Solutions (NASDAQ:SWKS) has been the subject of 9 analyst reviews over the past three months, showing a mix of bullish and bearish sentiments. The average 12-month price target among analysts is $102.22, down 10.86% from the previous target, with individual targets ranging from $83.00 to $120.00. Recent actions by analysts include downgrades in ratings and price targets by firms such as Citigroup, Wells Fargo, and UBS, reflecting adjustments to market conditions and company performance. Despite a negative revenue trend and challenges in market capitalization, Skyworks Solutions maintains a strong net margin and a sound debt management profile.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 1:00 pm

COST

Recent evaluations by 24 analysts on Costco Wholesale (NASDAQ:COST) show diverse opinions, with a shift towards a more bullish outlook in the last 30 days. The average 12-month price target for COST has increased by 5.04% to $779.38, with high and low estimates of $870.00 and $650.00, respectively. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting changes in market conditions and company performance. Costco's financial health is strong, with significant market capitalization, revenue growth, and efficient cost management.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 1:00 pm

TRIP

Tripadvisor (NASDAQ:TRIP) has been analyzed by 11 analysts, showing a shift towards a more neutral stance in the last three months with a total of 9 indifferent ratings recently. The average 12-month price target for TRIP has increased to $26.18, reflecting a 14.37% rise from the previous target of $22.89. Analysts' actions range from maintaining to raising their price targets, with the highest target set at $34.00 and the lowest at $20.00. Tripadvisor's financial performance indicates a positive revenue growth rate of 10.17% and a strong net margin of 8.21%, despite a high debt-to-equity ratio of 1.05.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 1:00 pm

MNMD

Mind Medicine (MindMed) Inc. presented new studies at ISPOR 2024, demonstrating the significant economic and societal impact of Generalized Anxiety Disorder (GAD) in the U.S. The studies, based on data from the 2022 National Health and Wellness Survey, showed that GAD increases healthcare costs, decreases work productivity, and lowers health-related quality of life. The impact is more severe in undiagnosed cases. MindMed is developing novel treatments for GAD and other brain health disorders.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:56 pm

IAS

PUBM

RBLX

Roblox Corp (NYSE:RBLX) stock plummeted after issuing a weaker-than-expected outlook for Q2 and fiscal year 2024, despite beating Q1 bookings and adjusted EPS estimates. The company reported a 19% year-on-year increase in bookings to $923.80 million and an adjusted EPS loss of $(0.43), surpassing analyst expectations. However, its Q2 bookings forecast of $870 million to $900 million and fiscal 2024 bookings forecast of $4.00 billion to $4.10 billion fell short of analyst consensus. Roblox also announced partnerships with Integral Ad Science Holding Corp (NASDAQ:IAS) and PubMatic, Inc (NASDAQ:PUBM) to expand video ad access and sales.

Portfolio Pulse from Anusuya Lahiri

May 09, 2024 | 12:55 pm

WU

Western Union, in partnership with Orbit S.A., has resumed its money transfer service from the U.S. to Cuba, allowing customers to send money to family members with accounts at specific Cuban banks. This service is available through U.S. retail locations, WesternUnion.com, and the Western mobile app, highlighting the company's commitment to maintaining vital financial connections between the U.S. and Cuba.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:50 pm

MOGO

Mogo, a financial technology company, projects an acceleration in its subscription and services revenue growth for 2024, expecting the overall growth rate to be in the mid-teens for the full year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:35 pm

NVO

Flagship Pioneering and Metaphore Biotechnologies have entered into a research collaboration with Novo Nordisk to develop next-generation therapeutics for obesity management. Novo Nordisk may pay up to $600 million in upfront, development, and commercial milestone payments.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:26 pm

SN

SharkNinja has updated its FY24 financial outlook, projecting an increase in adjusted net income per diluted share to $3.66-$3.82 from a prior estimate of $3.45-$3.61. Adjusted net sales are expected to grow 12%-14% YoY, up from the previous 7%-9% forecast. Adjusted EBITDA is anticipated to be between $840 million and $870 million, marking a 17%-21% increase from the prior year. The company also expects a GAAP effective tax rate of 24%-25%, diluted weighted average shares outstanding of approximately 141 million, and capital expenditures of $160 million to $180 million.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:20 pm

ERII

Energy Recovery has secured $15M in contracts to provide PX Pressure Exchanger devices to seawater reverse osmosis desalination plants in India, with all orders slated for shipment in 2024.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:16 pm